| Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics. | |
| | |
MedLine Citation:
|
PMID: 23331529 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: Subcutaneous immunoglobulin (SCIG) therapy is gaining favor for the management of primary immunodeficiency disease (PIDD) in adults and children. METHODS: A retrospective chart review captured data on 96 pediatric patients with PIDD using SCIG (16% or 20%) delivered by infusion pump or SC rapid push over 620 clinic visits. Patients previously using intravenous immunoglobulin (IVIG) were converted to SCIG dosing on a 1:1 basis. Patients/caregivers voluntarily chose an administration technique. RESULTS: Although mean SCIG dosing was lower on a g/kg/month basis compared with prior IVIG dosing, mean steady-state serum IgG levels during SCIG administration were about 100-200 mg/dl higher than IVIG trough values. On average, much more rapid infusion was achieved with the SC rapid push method, with 49% of patients reporting infusion times of 9 min or less; median duration of infusion pump administration was 45 min. The use of 20% SCIG increased dosing efficiency compared with 16% SCIG, allowing for a smaller weekly mean SCIG volume and fewer dosing days per week. Adverse event (AE) rates were lower in the pediatric subgroup compared with adults (15.8% vs. 18.8% of visits), and the majority of AEs were local. SC rapid push was reported most frequently for patients under age 2; its use decreased between ages 2 and <10 yr and then increased in adolescence and into adulthood. Only one of the pediatric patients returned to IVIG use. CONCLUSIONS: Administration of replacement Ig via SC rapid push is a safe and viable option in pediatric patients with PIDD. |
| | |
Authors:
|
Ralph S Shapiro |
Related Documents
:
|
23388479 - Comparison of the anti-inflammatory and therapeutic actions of ppar-gamma agonists rosi... 23380829 - Optimizing asparaginase therapy for acute lymphoblastic leukemia. 19756749 - Biological control of sheep gastrointestinal nematodiasis in a tropical region of the s... 11049909 - The use of intravenous atropine after a saline infusion in the prevention of spinal ane... 23328959 - Mega-dose intravenous octreotide for the treatment of carcinoid crisis: a systematic re... 23029119 - The monoamine re-uptake inhibitor uwa-101 improves motor fluctuations in the mptp-lesio... 8543979 - Continuous intravenous infusion of iodine-123-ibzm for spect determination of human bra... 1297639 - Clinical pharmacokinetics of teicoplanin and aminophylline during cotreatment with both... 3133339 - Pharmacokinetic approach to rational therapeutic doses for human tumor-bearing nude mice. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology Volume: 24 ISSN: 1399-3038 ISO Abbreviation: Pediatr Allergy Immunol Publication Date: 2013 Feb |
Date Detail:
|
Created Date: 2013-01-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9106718 Medline TA: Pediatr Allergy Immunol Country: England |
Other Details:
|
Languages: eng Pagination: 49-53 Citation Subset: IM |
Copyright Information:
|
© 2013 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd. |
Affiliation:
|
Midwest Immunology Clinic, Plymouth, MN, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Safety of mometasone furoate nasal spray in the treatment of nasal polyps in children.
Next Document: Herpesvirus infections and allergic sensitization in children of families with anthroposophic and no...